US Stock MarketDetailed Quotes

ETNB 89bio

Watchlist
  • 7.130
  • +0.210+3.03%
Close Jan 24 16:00 ET
  • 7.500
  • +0.370+5.19%
Post 20:01 ET
838.36MMarket Cap-2.41P/E (TTM)

About 89bio Company

89bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. The company was founded on January 18, 2018 and is headquartered in San Francisco, CA.

Company Profile

SymbolETNB
Company Name89bio
Listing DateNov 11, 2019
Issue Price16.00
Founded2018
CEOMr. Rohan Palekar
MarketNASDAQ
Employees70
Fiscal Year Ends12-31
Address655 Montgomery,Suite 1500
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94111
Phone1-415-432-9270

Company Executives

  • Name
  • Position
  • Salary
  • Rohan Palekar
  • Chief Executive Officer and Director
  • 5.59M
  • Ryan Martins
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Francis W. Sarena
  • Chief Operating Officer
  • --
  • Dr. Hank Mansbach, M.D.
  • Chief Medical Officer
  • 2.54M
  • Quoc Le-Nguyen
  • Chief Technical Operations Officer and Head of Quality
  • 2.51M
  • Dr. Steven M. Altschuler, M.D.
  • Chairman of the Board
  • 385.83K
  • Dr. Charles A. McWherter, PhD.
  • Director
  • --
  • Martin Babler
  • Director
  • --
  • Kathleen D. Laporte
  • Independent Director
  • 360.17K
  • Lota S. Zoth, C.P.A.
  • Independent Director
  • 363.33K
  • Dr. Michael Hayden
  • Independent Director
  • 358.33K
  • Dr. Edward Morrow Atkinson, III
  • Independent Director
  • 354.60K
  • Dr. Derek DiRocco, PhD
  • Independent Director
  • 352.33K

Trending Stocks

Discussing
As Tesla's earnings near, will its stock soar?
🎙️Discussion: 1. With Trump's return, can Tesla's stock price continue to rise in 2025? 2. Tesla is set to release its earnings report aft Show More